Biofrontera Inc. Basic Shares Outstanding (Weighted Average)
Biofrontera Inc. (BFRI) reported Basic Shares Outstanding (Weighted Average) of 12.92 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Biofrontera Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 12.92M shares, a 38.20% increase year-over-year.
- Biofrontera Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.68M shares, a 31.66% increase year-over-year.
- Biofrontera Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.66M shares, a 54.17% increase year-over-year.
- Biofrontera Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 10.78M shares, a 86.64% increase year-over-year.
- Biofrontera Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 10.17M shares, a 84.40% increase from fiscal 2024.
- Biofrontera Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 5.52M shares, a 256.74% increase from fiscal 2023.
- Biofrontera Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.55M shares, a 46.29% increase from fiscal 2022.
- Biofrontera Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 1.06M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 12.92M shares 10-Q · filed 2026-08-13 | 12.31M shares 10-Q · filed 2026-08-13 | 12.09M shares derived: average of 3 quarters · filed 2026-08-13 | 11.76M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 11.68M shares 10-Q · filed 2026-05-14 | 11.67M shares derived: average of 2 quarters · filed 2026-05-14 | 11.37M shares derived: average of 3 quarters · filed 2026-05-14 | 10.87M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 11.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 11.22M shares derived: average of 2 quarters · filed 2026-03-19 | 10.60M shares derived: average of 3 quarters · filed 2026-08-13 | 10.17M shares 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | 10.78M shares 10-Q · filed 2025-11-12 | 10.06M shares derived: average of 2 quarters · filed 2026-08-13 | 9.67M shares 10-Q · filed 2025-11-12 | 9.14M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 9.35M shares 10-Q · filed 2026-08-13 | 9.11M shares 10-Q · filed 2026-08-13 | 8.60M shares derived: average of 3 quarters · filed 2026-08-13 | 7.89M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 8.87M shares 10-Q · filed 2026-05-14 | 8.22M shares derived: average of 2 quarters · filed 2026-05-14 | 7.40M shares derived: average of 3 quarters · filed 2026-05-14 | 6.83M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 7.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 6.67M shares derived: average of 2 quarters · filed 2026-03-19 | 6.14M shares derived: average of 3 quarters · filed 2026-03-19 | 5.52M shares 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | 5.77M shares 10-Q · filed 2025-11-12 | 5.43M shares derived: average of 2 quarters · filed 2025-11-12 | 4.83M shares 10-Q · filed 2025-11-12 | 4.16M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 5.09M shares 10-Q · filed 2025-08-13 | 4.36M shares 10-Q · filed 2025-08-13 | 3.62M shares derived: average of 3 quarters · filed 2025-08-13 | 3.06M shares derived: average of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | 3.62M shares 10-Q · filed 2025-05-15 | 2.88M shares derived: average of 2 quarters · filed 2025-05-15 | 2.38M shares derived: average of 3 quarters · filed 2025-05-15 | 2.12M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 2.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 1.76M shares derived: average of 2 quarters · filed 2025-03-20 | 1.62M shares derived: average of 3 quarters · filed 2025-03-20 | 1.55M shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 1.37M shares 10-Q · filed 2024-11-14 | 1.36M shares derived: average of 2 quarters · filed 2024-11-14 | 1.35M shares 10-Q · filed 2024-11-14 | 1.34M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 1.36M shares 10-Q · filed 2024-08-14 | 1.36M shares 10-Q · filed 2024-08-14 | 1.33M shares derived: average of 3 quarters · filed 2024-08-14 | 1.28M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 1.33M shares 10-Q · filed 2024-05-15 | 26.70M shares 10-Q · filed 2023-05-12 | 1.31M shares derived: average of 2 quarters · filed 2024-05-15 | 1.26M shares derived: average of 3 quarters · filed 2024-05-15 | 1.18M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 1.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 1.22M shares derived: average of 2 quarters · filed 2024-03-15 | 1.12M shares derived: average of 3 quarters · filed 2024-03-15 | 1.06M shares 10-K · filed 2024-03-15 | 21.14M shares 10-K · filed 2023-03-13 | |||
| 2022-09-30 | 1.14M shares 10-Q · filed 2023-11-09 | 22.73M shares 10-Q · filed 2022-11-14 | 1.04M shares derived: average of 2 quarters · filed 2023-11-09 | 978.02K shares 10-Q · filed 2023-11-09 | 19.56M shares 10-Q · filed 2022-11-14 | -764.03K shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 941.17K shares 10-Q · filed 2023-08-11 | 18.82M shares 10-Q · filed 2022-08-12 | 898.44K shares 10-Q · filed 2023-08-11 | 17.97M shares 10-Q · filed 2022-08-12 | -1.40M shares derived: average of 3 quarters · filed 2023-10-03 | 951.89K shares derived: average of 4 quarters · filed 2023-10-03 | ||
| 2022-03-31 | 17.10M shares 10-Q · filed 2023-05-12 | -2.57M shares derived: average of 2 quarters · filed 2023-10-03 | 955.47K shares derived: average of 3 quarters · filed 2023-10-03 | 2.72M shares derived: average of 4 quarters · filed 2023-10-03 | ||||
| 2021-12-31 | -22.24M shares derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | -7.12M shares derived: average of 2 quarters · filed 2023-10-03 | -2.08M shares derived: average of 3 quarters · filed 2023-10-03 | 440.41K shares 8-K · filed 2023-10-03 | 8.81M shares 10-K · filed 2023-03-13 | |||
| 2021-09-30 | 8.00M shares 10-Q · filed 2022-11-14 | 8.00M shares derived: average of 2 quarters · filed 2022-11-14 | 8.00M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 8.00M shares 10-Q · filed 2022-08-12 | 8.00M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 8.00M shares 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |